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Abstract
Chromosomal instability in early cancer stages is caused by repli-
cation stress. One mechanism by which oncogene expression
induces replication stress is to drive cell proliferation with insuffi-
cient nucleotide levels. Cancer development is driven by alter-
ations in both genetic and environmental factors. Here, we
investigated whether replication stress can be modulated by both
genetic and non-genetic factors and whether the extent of replica-
tion stress affects the probability of neoplastic transformation. To
do so, we studied the effect of folate, a micronutrient that is
essential for nucleotide biosynthesis, on oncogene-induced tumori-
genicity. We show that folate deficiency by itself leads to replica-
tion stress in a concentration-dependent manner. Folate deficiency
significantly enhances oncogene-induced replication stress, leading
to increased DNA damage and tumorigenicity in vitro. Importantly,
oncogene-expressing cells, when grown under folate deficiency,
exhibit a significantly increased frequency of tumor development
in mice. These findings suggest that replication stress is a quanti-
tative trait affected by both genetic and non-genetic factors and
that the extent of replication stress plays an important role in
cancer development.
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Introduction
Chromosomal instability is a hallmark of nearly all solid tumors
and adult-onset leukemias (Hanahan & Weinberg, 2011). Enormous
efforts have been made in the last few decades to understand the
cellular and environmental factors leading to genomic instability
and cancer development (Lengauer et al, 1998; McGranahan et al,
2012; Ozeri-Galai et al, 2012). In recent years, it has become
apparent that in early stages of cancer development, DNA instabil-
ity is caused by perturbed DNA replication (Ames & Wakimoto,
2002; Gorgoulis et al, 2005; Tsantoulis et al, 2008). This replication
stress is defined as perturbations in the dynamics of the replication
machinery and is characterized by slow fork progression, and in
some cases even fork collapse, activation of additional origins, and
asymmetric progression of replication forks emerging from the
same origin (Hills & Diffley, 2014). In the early stages of cancer
development, oncogene activation leads to replication stress
(Bartkova et al, 2005; Di Micco et al, 2006; Tsantoulis et al, 2008;
Bester et al, 2011), which underscores the role of DNA replication
in cancer development (Halazonetis et al, 2008; Negrini et al,
2010). Several mechanisms by which oncogenes induce replication
stress were recently identified, including insufficient nucleotide
pools to support the extensive enforced DNA replication (Bester
et al, 2011; Mannava et al, 2013), interference with the pre-replica-
tion complex assembly (Ekholm-Reed et al, 2004) and the collision
between replication and transcription (Jones et al, 2013). However,
it remains unclear whether the extent of the replication stress can
affect the probability of neoplastic transformation. Moreover,
whether enhanced replication stress can be driven by a combina-
tion of genetic, cellular, and environmental factors is largely
unknown.
Micronutrients are important environmental factors for normal
cellular proliferation. Suboptimal levels (a deficiency) of micronu-
trients increase the risk of many types of cancer (reviewed in
(Vidal et al, 2011; Ames & Wakimoto, 2002). One classic exam-
ple of such a micronutrient is folate, a B9 water-soluble vitamin
found mainly in green leafy vegetables (Camilo et al, 1996).
Folate is the general term for many derivatives found in intracel-
lular equilibrium, which except for de novo synthesis by intesti-
nal microflora cannot be produced by most mammals (Camilo
et al, 1996). Folic acid is the fully oxidized monoglutamyl form
of folate, which is frequently used as a nutritional supplement.
Therefore, folate must be obtained from dietary or supplementary
sources (Shane, 1989). Folate is required for one-carbon transfer
reactions including the synthesis of thymidine and purines and
the methylation of cytosines in DNA (reviewed in (Duthie, 2011;
Kim, 1999b; Shane, 1989). It has been shown that folate
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deficiency caused by the use of antifolate reagents perturbs the
size and balance of the nucleotide pool (Shane, 1989). However,
the effect of folate deficiency on DNA replication dynamics
remains unclear.
Many epidemiological studies have shown that suboptimal levels
of folate are associated with several types of cancer, including colon
(Giovannucci et al, 1995; Zhang et al, 1999; Rohan et al, 2000),
cervical (Rampersaud et al, 2002; Garcı´a-Closas et al, 2005), gastric,
and esophageal cancers (Mayne et al, 2001). Studies in human
cultured cells and in vivo studies in both animal models and
humans have shown that severe folate deficiency is associated with
double-strand breaks (DSBs), chromosome instability, and micro-
nuclei formation (Chen et al, 1989; James & Yin, 1989; Duthie &
McMillan, 1997; MacGregor et al, 1997; Pogribny et al, 1997;
Melnyk et al, 1999; Duthie et al, 2000a,b, 2008; Beetstra et al,
2005). The main mechanism linking folate deficiency to DNA
damage is presumed to be the incorporation of dUMP into the DNA,
which is thought to culminate in futile cycles of uracil excision,
single-strand breaks, and possibly chromosomal breakage (Blount
et al, 1997). Importantly, it was shown that folate deficiency
enhances the activity of various chemical carcinogens in numerous
organs (Eto & Krumdieck, 1986). To date, however, a mechanism
that can account for the co-carcinogenic role of folate deficiency has
yet to be found.
Folate deficiency has a dual effect on the tumorigenic potential
of the cells depending on the duration and extent of the folate
deficiency and on the cell stage (tumorigenicity). In neoplastic
cells, there is extensive DNA replication and cell division. In these
cells, folate deficiency causes ineffective DNA synthesis, resulting
in inhibition of tumor growth (Kim, 1999a,b; Choi & Mason,
2002). Indeed, this has been the basis for cancer chemotherapy
using a number of antifolate agents (e.g., methotrexate and
5-fluorouracil) (Kim, 1999a,b; Choi & Mason, 2002). Like most
chemotherapies, antifolate drugs are toxic to both normal and
neoplastic cells and prolonged folate deficiency eventually results
in growth arrest and cell death regardless of the tumorigenicity of
the cells. However, under shorter and milder folate deficiency
conditions, neoplastic cells and other extensive proliferating cells
will die, whereas normal cells will survive. An accumulating body
of epidemiological, clinical, and experimental evidence suggests
that normal cells that survived folate deficiency are predisposed to
neoplastic transformation (Kim, 1999a,b, 2003). This dual effect of
folate deficiency, which is also known as the “double-edged
sword” effect, explains why methotrexate therapy is associated
with increased risk of secondary malignancy (Schmiegelow et al,
2009).
In the current study, we investigated the combined effect of
genetic and dietary factors on replication dynamics, genome
stability, and cancer development. Our results show that subopti-
mal levels of folate lead to replication stress and DSBs in a
concentration-dependent manner. Importantly, folate deficiency
significantly enhances oncogene-induced replication stress, DNA
damage, and tumorigenicity in vitro. Furthermore, oncogene-
expressing cells grown under folate deficiency show a significant
increase in the frequency of tumor development in mice. These
findings suggest that replication stress is a quantitative trait that
can be affected by both genetic and non-genetic (e.g., dietary)
factors.
Results
Folate deficiency perturbs cellular DNA replication dynamics
To investigate the role of folate levels in tumorigenesis, we first
analyzed the effects of folate deficiency on DNA replication dynam-
ics. For this purpose, immortalized primary foreskin fibroblasts
(BJ-hTert) were grown for 7 days in a folate-free medium (folate-free
DMEM). During this time, the folate-deficient cells exhibited a similar
growth rate as their counterparts that were cultured in a normal
medium (Fig 1A), indicating that differences between the cultures
were not a result of impaired growth. To investigate the effect of the
folate-free medium on cellular DNA replication, we took advantage
of the high-resolution DNA combing approach which enables repli-
cation analysis on single DNA molecules. The newly synthesized
DNA, labeled with IdU and CldU, can be detected by fluorescent
antibodies (green and red, respectively) (Fig 1B). First, we analyzed
the effect of folate deficiency on the cellular replication fork rate
(Fig 1C and D). The results showed a dramatic decrease in the mean
replication rate, from 1.59 Kb/min in cells cultured in a normal
medium to 0.78 Kb/min in cells grown in a folate-free medium
(P < 1.6 × 1032). Importantly, a dramatic increase in the percent-
age of very slow forks (0.75 Kb/min and below) was observed
following growth in a folate-free medium (from 3% under normal
conditions to 54% under folate deficiency; Fig 1D). Similar results
were obtained in three independent experiments (Fig 1E; Appendix
Fig S1A). These results indicate that folate deficiency leads to a
significant decrease in fork progression rate.
When DNA replication is perturbed, the number of active origins
increases in an attempt to compensate for the slow fork progression
(Anglana et al, 2003; Ge et al, 2007; Courbet et al, 2008). For this
reason, we studied the effect of growth in a folate-free medium on
Figure 1. Growth rate and replication dynamics in BJ cells grown in a folate-free medium with and without nucleoside supplementation.
A Population doublings (PDs) determined in BJ cells cultured with and without folate for 28 days.
B Example of a single combed DNA molecule labeled with IdU (green) and CldU (red), showing replication from three adjacent origins. Horizontal white arrows indicate
fork orientation.
C Representative examples of single combed DNA molecules from control cells and cells grown for 7 days in a folate-free medium.
D Fork rate (Kb/min) distribution. Light blue bars: BJ cells (n = 126); black bars: BJ cells that were cultured for 7 days in a folate-free medium (n = 131);
blue bars: BJ cells cultured for 7 days in a folate-free medium and supplemented with A, G, C, and T nucleosides for the last 48 h of the experiment (n = 138).
E Box plot summarizing the fork rate distribution (Kb/min) of three independent experiments. Control (n = 360); folate (n = 372); folate + AGCT (n = 361).
F Fork distance (Kb) distribution. The color code is as in (D). Control (n = 72); folate (n = 71); folate + AGCT (n = 75).
G Box plot summarizing the fork distance distribution (Kb) of three independent experiments. Control (n = 212); folate (n = 215); folate + AGCT (n = 209).
Data information: (E, G) Main box represents the values from the lower to upper quartile (25th to 75th percentile). The middle line represents the median. **P < 0.0001.
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origin density by measuring the distance between two sister forks,
which in unsynchronized cells is approximately half of the replicon
length (Maya-Mendoza et al, 2007). The replicon length scales with
increasing inter-origin distances and is therefore a readout of the
distance between activated origins. The results showed a significant
decrease in the mean fork distance from 195 Kb in the control cells
to only 107 Kb in the folate-deficient cells (P < 4 × 1011) (Fig 1C
and F). Similar results were obtained in three independent experi-
ments (Fig 1G; Appendix Fig S1B). Altogether, these results indicate
that folate deficiency leads to dramatic replication perturbations. We
hypothesized that this observed replication stress was due to an
insufficient nucleotide pool generated by folate deficiency. For this
purpose, BJ cells were grown for 7 days in a folate-free medium and
were supplemented with 50 lM of each of the four nucleosides for
the last 48 h. Evaluating the replication dynamics using DNA comb-
ing revealed that the exogenous supply of nucleosides almost
completely restored the average fork rate (Fig 1D and E; Appendix
Fig S1A) and the average fork distance (Fig 1F and G; Appendix Fig
S1B). Using the high-performance liquid chromatography (HPLC)
method, the concentrations of the cellular dNTPs were measured.
As expected, the concentration of the cellular dTTP in cells grown
under folate deficiency for 15–30 days was significantly reduced
compared to the concentration in same cells grown in a normal
medium (Appendix Fig S2). The levels of the dATP, dGTP, and dCTP
were below detection. Since the level of dTTP in the folate-deficient
medium is very low, uracil misincorporation into the DNA in the
cells is expected (Duthie & Hawdon, 1998; Fenech, 2012).
The extent of replication stress is affected by the levels and
duration of folate deficiency
In cultured cells, a folate concentration in the 12–120 nM range was
shown to be negatively correlated with DNA damage and micronu-
clei formation (reviewed in Fenech, 2012). Whereas 20 nM is
considered a severe folate deficiency in tissue cultured cells and
100 nM is considered to be mild, 500 nM has not, to the best of our
knowledge, been reported to induce any DNA damage. Hence, we
studied the effect of different folate concentrations on replication
dynamics. We grew BJ cells in a folate-free medium and in a
medium containing 20, 100, 500, and 9,040 nM folate. The latter is
the regular concentration in the commercial DMEM.
First, the effect of various folate concentrations on cell growth
was studied by analysis of population doublings (PDs). As can be
seen in Fig 2A, the effect was concentration dependent. Cells
cultured with 500 nM folate showed a similar growth rate as control
cells during the 48 days of culturing, whereas cells cultured with
100 nM folate showed a reduced growth rate, but continued to grow
during the whole experiment. In contrast, cells cultured with 20 nM
folate showed a major decrease in growth rate starting at ~21 days
of culturing and stopped growing after ~35 days. The effect of the
folate-free medium was even stronger, leading to growth arrest after
only 21 days (Fig 2A).
Next, we studied the effect of various folate concentrations on
the DNA replication dynamic in cells grown for 14 and 21 days
(Fig 2B and C). On day 14, cells cultured at 100 nM, 20 nM, or in a
folate-free medium exhibited a concentration-dependent decrease in
the average fork rate and distance (Fig 2B and C). Consistent with
the above, the average fork rate and distance did not significantly
differ between cells cultured with 500 nM folate and the control
cells (Fig 2B and C). The effect of folate deficiency on the average
replication rate and fork distance significantly increased with time
(Fig 2B and C). Remarkably, cells grown in a medium with 500 nM
folate, which did not affect cell proliferation (Fig 2A), also showed a
significant decrease in their average replication rate with time: After
14 days, the replication rate was 1.22 Kb/min (the same rate as in
the control cells), whereas after 21 days the rate was significantly
lower (Fig 1B). The average fork distance in the 500 nM folate
cultures decreased during this period of time from 127 to 97 Kb
(Fig 1C).
We further analyzed the effect of nucleoside supplementation on
replication stress under mild folate deficiency. As can be seen in
Fig 2, BJ cells grown for 14 days in 100 nM folate showed a reduced
replication rate (from 1.2 to 0.9 Kb/min) (P < 4.1 × 1010) (Fig 2B
and D). Similar results were obtained in three independent experi-
ments (Fig 2E). In accordance with the reduced replication rate, the
fork distance reduced from an average of 136 to 85 Kb
(P < 2.3 × 103) (Fig 2C and F). Similar results were obtained in
three independent experiments (Fig 2G). Supplementation of nucle-
osides for 48 h resulted in almost complete rescue of the average
fork rate (P < 3.3 × 109) and distance (P < 0.005), (Fig 2D–G). It
is worth noting that the replication stress preceded the impaired
proliferation, since cell growth for 14 days in 100 nM folate showed
perturbed replication dynamics but no effect on cell proliferation.
This indicates that the replication stress induced by folate deficiency
was not secondary to decreased proliferation.
Altogether, our data show that the extent of replication stress is
determined by folate deficiency in a concentration-dependent manner.
Moreover, the effect of folate deficiency exacerbates with time, and
even a mild chronic suboptimal folate level that does not hinder cell
proliferation eventually results in stress on DNA replication.
Figure 2. Growth rate and replication dynamics in BJ cells grown under various folate concentrations with and without nucleoside supplementation.
A Population doublings (PDs) determined in BJ cells cultured at the indicated folate concentrations for 48 days.
B, C The average replication rate  SEM (B) and the average fork distance  SEM (C) in the indicated folate concentrations at 14 and 21 days. At least 115 DNA fibers
were analyzed at each concentration and at each time point to determine the average replication rate. At least 71 replication forks were analyzed at each
concentration and at each time point to determine the average fork distance.
D–G BJ cells were grown for 14 days in 100 nM folate with and without nucleoside supplementation. (D) Fork rate (Kb/min) distribution. Light blue bars: BJ cells
(n = 115); gray bars: BJ cells that were cultured for 14 days in 100 nM folate (n = 117); blue bars: BJ cells cultured for 14 days in 100 nM folate and supplemented
with A, G, C, and T nucleosides for the last 48 h of the experiment (n = 117). (E) Box plot summarizing the fork rate distribution (Kb/min) of three independent
experiments. Control (n = 352); 100 nM folate (n = 364); 100 nM folate + AGCT (n = 355). Main box represents the values from the lower to upper quartile (25th to
75th percentile). The middle line represents the median. (F) Fork distance (Kb) distribution. The color code is as in (D). Control (n = 69); 100 nM folate (n = 74);
100 nM folate + AGCT (n = 72). (G) Box plot summarizing the fork distance distribution (Kb) of three independent experiments. Control (n = 201); 100 nM folate
(n = 220); 100 nM folate + AGCT (n = 228). Main box represents the values from the lower to upper quartile (25th to 75th percentile). The middle line represents
the median. **P < 0.001.
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Enhanced replication stress and DNA damage in oncogene-
expressing cells caused by folate deficiency
Next, we studied whether the replication stress conferred by folate
deficiency can enhance the replication stress induced by an onco-
gene. First, we expressed the oncogene cyclin E, which is
frequently overexpressed in many types of human precancerous
and cancerous lesions (Hwang & Clurman, 2005). Aberrant expres-
sion of cyclin E was shown to induce replication stress (Bester
et al, 2011; Jones et al, 2013). Using retroviral infection, BJ cells
were transfected with a cyclin E construct. Cyclin E expression was
verified by Western blot analysis (Appendix Fig S3A). The experi-
ments were performed in newly transformed cells, no later than
6 weeks following cyclin E infection. Cells were cultured for 7 days
in a normal or folate-free medium. As can be seen in Fig 3, folate
deficiency significantly enhanced the replication stress conferred by
cyclin E expression. Whereas cyclin E expression by itself
decreased the average replication rate from 1.18 Kb/min in cells
expressing an empty vector to 0.79 Kb/min (P < 2.4 × 1021),
folate deficiency further reduced the average replication rate to
0.59 Kb/min (P < 1 × 1013) (Fig 3A). The fraction of very
slow replicating forks found in cyclin E-expressing cells was
further increased when cells were cultured in a folate-free
medium (Fig 3A). Similarly, the average fork distance was further
decreased when cyclin E-expressing cells were cultured in a
folate-free medium, from 129 Kb in the control cells to 94 Kb in
cyclin E-expressing cells (P < 8.4 × 104) and to 70 Kb in
cyclin E-expressing cells grown in a folate-deficient medium
(P < 1 × 103) (Fig 3B). Similar results were obtained in three
independent experiments (Appendix Fig S3B and C).
Two replication forks that emerge from the same origin (sister
forks) tend to exhibit the same replication rate (Anglana et al,
2003). However, under replication stress conditions, perturbed fork
progression might lead to asymmetric progression of the sister forks
(Di Micco et al, 2006). As previously suggested (Anglana et al,
2003), the progression of sister forks is considered symmetric when
the ratio between them is > 0.75. Our analysis revealed a significant
increase in the asymmetry between sister forks, from 23% in the
control cells to 42% in cells grown under folate deficiency and 43%
in cyclin E-expressing cells (Fig 3C). Importantly, cyclin E-expressing
cells grown under folate deficiency showed a further increase in
the fraction of asymmetric forks to 67% (Fig 3C). These results
indicate that the replication perturbation induced by aberrant onco-
gene expression can be enhanced by an additional source of stress
such as folate deficiency.
Next, we studied the effect of folate deficiency in cells expressing
another oncogene, the human papilloma virus 16 (HPV16) E6/E7.
In recent years, a correlation between folate deficiency and the
development of HPV-induced cervical carcinoma has been reported
(Rampersaud et al, 2002; Garcı´a-Closas et al, 2005). We further
investigated the effect of folate deficiency on replication dynamics
in primary keratinocytes derived from adult skin biopsies expressing
the HPV16 oncogenes E6/E7. This is a highly powerful model
system for studying events in early stages of cervical cancer devel-
opment, as primary keratinocytes are the natural host for HPV infec-
tion. All the experiments were performed in newly transformed cells
2–6 weeks following E6/E7 infection and before anaphase bridges
and micronuclei were visible. Replication analysis was performed
on E6/E7-expressing cells grown in a normal and a folate-free
medium for 4 weeks. The average replication rate of the E6/E7-
expressing keratinocytes in the normal medium was 0.79 Kb/min,
whereas in the folate-free medium the average fork rate was
significantly reduced to 0.58 Kb/min (P < 1.5 × 105) (Appendix
Fig S4A), indicating that folate deficiency significantly enhances the
effect of E6/E7 oncogenes on cellular DNA fork progression. We
further studied the effect of folate deficiency on fork distance. We
found that in E6/E7-expressing cells grown in a folate-free medium,
the average fork distance was significantly shorter than in E6/E7-
expressing cells grown in a normal medium (P < 5 × 103)
(Appendix Fig S4B). Overall, our data show that the enhancement
of oncogene-induced replication stress by folate deficiency is not
oncogene or cell type specific.
We further studied the effect of folate deficiency on genome
stability by analyzing the formation of DSBs (indicated by the
cH2AX-53BP1 foci) in cyclin E-expressing cells grown for 7 days in
a folate-free medium. Cyclin E-expressing cells cultured in the
folate-free medium showed a significant increase in the number of
cH2AX-53BP1 foci per nucleus compared to each treatment by itself
(average of 7.8 and 4.6 foci/cell, respectively, Fig 3D and E). In
particular, the fraction of cells with a high level of cH2AX-53BP foci
increased in cyclin E-expressing cells from 4% in the control cells to
25%. This fraction was further increased in cyclin E-expressing cells
cultured in a folate-free medium, in which 32% of the nuclei
showed a high level of cH2AX-53BP1 foci (Fig 3D and E).
We further characterized the effect of folate deficiency on DNA
damage signaling. For this, we studied the activation of the two
main signal transduction pathways that inhibit cell-cycle progression
following DNA damage, and the ATM and ATR pathways (Kastan
& Bartek, 2004). The ATM protein is a member of the phos-
phatidylinositol 3-kinase family of proteins that respond to DNA
Figure 3. The effect of folate deficiency on replication dynamics and DSB formation in cyclin E-expressing cells.
Cyclin E-expressing BJ cells were grown for 7 days with and without folate.
A Fork rate (Kb/min) distribution. White bars: BJ cells expressing an empty vector (n = 145); dark gray bars: BJ cells expressing the cyclin E oncogene (n = 147); light
gray bars: BJ cells cultured for 7 days in a folate-free medium (n = 135); black bars: BJ cells expressing the cyclin E oncogene cultured for 7 days in a folate-free
medium (n = 138).
B Fork distance distribution (Kb). The color code is as in (A). Empty vector (n = 78); CycE (n = 79); empty vector folate (n = 71); CycE folate (n = 80).
C Percent of origins with the indicated progression ratio between sister forks. Empty vector (n = 158); CycE (n = 155); empty vector folate (n = 160); CycE folate
(n = 154). *P < 0.05.
D Examples of nuclei with cH2AX and 53BP1 foci following cyclin E expression (CycE) (n = 65), empty vector (n = 65), folate-free medium for 7 days (empty vector
folate) (n = 67) or oncogene expression under folate-free conditions (CycE folate) (n = 70). Red: cH2AX; green: 53BP1; blue: DAPI staining.
E Percent of nuclei with the indicated number of cH2AX-53BP1 co-localized foci. **P < 0.01.
Data information: Bars represent average values.
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damage by phosphorylating key substrates involved in DNA repair
and/or cell-cycle control. The level of phosphorylated ATM was
analyzed by Western blot analysis using an antibody against
phosphorylated ATM (Fig 4A and B). The results showed that
cyclin E expression led to more than a twofold increase in the level
of phosphorylated ATM. Folate deficiency by itself led to an
A
E
B
????? Merge
Empty vector
CycE
?????????????
???????
CycE-Folate
D
Empty vector Empty vector-Folate CycE - Folate
0%
10%
20%
30%
40%
%
of
fo
rk
s
50%
Kb/min
0-0.25
0.25-0.5
0.5-0.75
0.75-1
1-1.25
1.25-1.5
1.5-1.75
1.75-2
%
of
fo
rk
s
0%
10%
20%
30%
40%
50%
60%
Kb
0-60
60-100
100-140
140-180
180-220
220-260
%
of
ce
lls
Empty vector-Folate
Empty vector
CycE CycE-Folate
  0
  20
  40
  60
  80
  100
%
of
 fo
rk
s
Empty vector-Folate
Empty vector
CycE CycE-Folate
C
  0
  20
  40
  60
  80
  100
10+
6-9
2-5
0-1
Foci/cell
Out-going forks ratio
CycE Empty vector Empty vector-Folate CycE - FolateCycE
-H2AX
Figure 3.
EMBO Molecular Medicine Vol 7 | No 9 | 2015 ª 2015 The Authors
EMBO Molecular Medicine Enhanced oncogene-induced stress by folate deficiency Noa Lamm et al
1144
increase of ~1.5-fold in the level of phosphorylated ATM (Fig 4A
and B). Importantly, the combined effect resulted in more than a
2.5-fold increase in the level of phosphorylated ATM (Fig 4A and
B). Next, we studied the activation of the ATR pathway by analyz-
ing the level of phosphorylated CHK1 which is increased under
DNA damage, preferentially by ATR (Kastan & Bartek, 2004). As
can be seen in Fig 4A and B, both cyclin E expression and folate
deficiency resulted in increased levels of phosphorylated CHK1.
Importantly, in cyclin E-expressing cells grown under folate defi-
ciency, the increase in the phosphorylated CHK1 level was higher
than in each treatment by itself (Fig 4A and B). Altogether, these
results show that cyclin E expression and folate deficiency lead to
the activation of both ATM and ATR signaling pathways, as found
in other cellular stress responses (Kastan & Bartek, 2004). Impor-
tantly, the activation of both ATM and ATR signaling pathways
was enhanced by the combination of oncogene expression and
folate deficiency.
Next, we studied RAD51 foci formation in response to folate
deficiency. RAD51 plays a critical role in homologous recombina-
tion and therefore in DSB repair (Petermann et al, 2010). Further-
more, RAD51 was recently shown to be essential for replication
fork reversal and restart upon different types of replication stress
conditions (Zellweger et al, 2015). As can be seen in Fig 4C and D,
cyclin E-expressing cells cultured in a folate-free medium showed a
significant increase in the number of RAD51 foci per nucleus
compared to the number in each treatment by itself. The fraction of
cells with RAD51 foci increased in cyclin E-expressing cells from
15% in the control cells to 35% (Fig 4C and D). This fraction was
further increased in cyclin E-expressing cells cultured in a
folate-free medium, in which almost half of the nuclei showed
RAD51 foci (Fig 4C and D). Altogether, these results indicate that
the extent of oncogene-induced replication stress can be enhanced
by an additional source of stress, resulting in enhanced DNA
damage.
Enhanced tumorigenicity in oncogene-expressing cells caused by
folate deficiency both in vitro and in vivo
We next investigated whether the enhanced genomic instability
caused by folate deficiency enhances cancer development. For this
purpose, we performed a standard in vitro transformation assay that
measures anchorage-independent growth in soft agar in both mouse
and human cells. We analyzed the colony-forming capacity of
mouse 3T3 cells expressing either the human cyclin E or the
oncogenic Ras (H-RasV12). Cells were grown for 4 weeks in a
normal medium or in a mild folate-deficient medium (100 nM) and
then for 2 more weeks in a normal medium, to allow recovery of
the cells from proliferation arrest due to the prolonged growth in
folate-deficient conditions. This enabled evaluation of the tumori-
genicity potential of the cells due to the folate deficiency-induced
DNA damage. Mild folate deficiency by itself did not affect the
colony-forming capacity of the cells (Fig 5A and B). However, mild
folate deficiency significantly increased colony formation caused by
oncogene expression from an average of 84 colonies per plate in the
3T3 cyclin E-expressing cells grown in a normal medium to 127 per
plate in the 3T3 cyclin E-expressing cells grown under mild
folate deficiency conditions (P < 0.05) (Fig 5A and B). Similar
results were found following the expression of the oncogene Ras.
Activating mutations in Ras such as G12V are found in many
human cancers (Karnoub & Weinberg, 2008), and lead to DSBs that
result in structural as well as numerical instability (Denko et al,
1994; Spruck et al, 1999; Abulaiti et al, 2006). Our analysis showed
that Ras expression by itself significantly induced colony formation
from 22 colonies per plate in the control cells to 134 in the
Ras-expressing cells (P < 0.01) (Fig 5A and B). Similar to the effect
of folate deficiency on cyclin E-expressing cells, mild folate
deficiency significantly increased colony formation in the Ras-
expressing cells from 134 to 191 per plate in cells grown in the mild
folate-deficient medium (P < 0.05) (Fig 5A and B). It is important
to note that 3T3 cells grown in a medium with a severe folate
deficiency (20 nM folate) or in a folate-free medium stopped
growing within 2 weeks, with or without the expression of cyclin E
or Ras.
Next, we studied the effect of folate deficiency on colony forma-
tion in immortal human cells aberrantly expressing the oncogenic
Ras. We used immortal human breast MCF10A cells transformed by
oncogenic Ras, grown for 4 weeks in a normal medium or in a mild
folate-deficient medium (100 nM folate) and for an additional
2 weeks in a normal medium. The results showed that folate
deficiency significantly increased colony formation caused by Ras
expression from 81 colonies per well in MCF10A-Ras-expressing
cells grown in a normal medium to 120 in MCF10A-Ras-expressing
cells grown in mild folate deficiency conditions (Fig 5C and D).
These results indicate that the in vitro tumorigenic potential of cells
aberrantly expressing an oncogene is significantly enhanced by mild
folate deficiency.
We further investigated the effect of folate deficiency in onco-
gene-expressing cells on tumor development in vivo. For this
purpose, we injected Ras-transformed MCF10A cells, grown
4 weeks in a normal medium or in a mild folate-deficient medium
(100 nM folate) and for an additional 2 weeks in a normal medium
into (Atimic-Nu/Nu) nude mice. The results showed that in mice
injected with MCF10A-Ras cells grown in a folate-deficient medium,
the percentage of developed tumors was significantly higher than in
those mice injected with cells grown in a normal medium (72 and
28%, respectively) (Fig 5E). These results clearly demonstrate that
folate deficiency significantly enhances tumor development caused
by oncogene expression in vivo.
Discussion
Here, we show that the extent of replication stress plays an
important role in prompting genomic instability and tumor develop-
ment in vivo (Figs 3–5). Our results indicate that replication-induced
genome instability and tumorigenicity can be induced by both
genetic and non-genetic (e.g., dietary) factors. We found that
micronutrients such as folate can significantly enhance the replica-
tion stress caused by oncogene expression and therefore reinforce
cancerous processes (Figs 3–5). Strikingly, the percentage and not
the size of the developing tumors was significantly higher when
oncogene-expressing cells were grown under folate-deficient conditions.
This suggests that the effect of folate deficiency on tumorigenicity
cannot be merely explained by its effect on cell proliferation but
rather by acting as an additional driving force enhancing the
oncogene-induced transformation.
ª 2015 The Authors EMBO Molecular Medicine Vol 7 | No 9 | 2015
Noa Lamm et al Enhanced oncogene-induced stress by folate deficiency EMBO Molecular Medicine
1145
Notably, enhanced tumorigenicity both in vitro and in vivo was
found after injection of cells that were allowed to recover for several
passages after the folate deficiency regime. This implies that even a
transient folate deficiency is sufficient to disrupt genome integrity
and enhance tumorigenicity, as DNA damage that was generated
under conditions of folate deficiency is irreversible and thus cannot
be recovered subsequent to later folate supplementation. Altogether,
our results show that in vivo development of cancer is mediated by
a combination of genetic and non-genetic factors that affects the
extent of replication-induced genomic instability.
Diet is estimated to contribute to about one-third of preventable
cancers (reviewed in (Ames & Wakimoto, 2002), but the mecha-
nisms by which dietary micronutrients promote DNA damage and
carcinogenesis are not fully understood. The principal mechanism
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linking folate deficiency to DNA damage is thought to be the
incorporation of dUMP into the DNA (Blount et al, 1997). Here, we
showed that folate deficiency affects genome stability even earlier,
as it perturbs the replication dynamics that lead to replication
stress-induced genome instability.
Recently, growth under folate-free conditions was shown to
increase the frequency of HPV16 infections and the transformation
of HPV16-infected tissues (Xiao et al, 2012). The proposed mecha-
nism in that study was alteration in cellular–viral protein interac-
tions, due to activation of a nutrition-sensitive posttranscriptional
RNA operon. Our work, however, suggests a general mechanism for
the effect of folate in oncogene-expressing cells, by showing that
folate deficiency in both cellular and viral oncogene-expressing cells
(BJ cells expressing cyclin E and keratinocytes expressing HPV16
E6/E7 oncogenes, respectively) enhances DNA replication stress,
resulting in increased genomic instability and tumorigenicity
(Figs 3–5; Appendix Figs S3 and S4).
Acute deficiencies of vitamins and minerals are rare in developed
countries; however, suboptimal intake is a widespread problem that
can lead to considerable cellular damage (Ames & Wakimoto,
2002). Our data show a concentration-dependent effect of folate
deficiency on replication dynamics. Interestingly, even a very mild
deficiency reduced the replication rate and fork distance over time
(Fig 2), demonstrating that a mild (suboptimal) but chronic folate
deficiency might be extremely significant in association with genetic
changes in cancer genes.
It would be valuable to relate the in vitro values to physiological
values. This is extremely challenging, primarily because folate is
supplemented in tissue culture media as folic acid while in vivo it is
provided through nutrition in the form of various folate derivatives,
whose cellular uptake is much more efficient than the uptake effi-
ciency of folic acid. Moreover, differences among individuals in the
efficiency to absorb and metabolize this vitamin (reviewed in
Fenech, 2012) also affect the actual folate level in vivo. Further
epidemiological, clinical, and interventional studies are required to
determine the physiological levels of folate deficiency and the defi-
ciency duration that affect replication dynamics.
The proliferation of normal primary cells was arrested under
prolonged mild or severe folate deficiency (0–100 nM) (Figs 1 and
2). During this period, the cells accumulated replication stress lead-
ing to genome instability. In the same cells expressing an oncogene,
the effect of folate deficiency significantly enhanced the replication
stress and genome instability induced by the oncogene (Figs 3 and
4). When folate levels returned to normal, the oncogene-expressing
cells showed a significantly higher tumorigenic potential compared
to the potential of their counterparts grown under normal conditions
(Fig 5). These results show that cells expressing an oncogene for a
short time have increased sensitivity to folate deficiency than both
normal cells and oncogene-expressing cells grown under folate
deficiency.
Furthermore, these results may explain the development of
secondary malignancies following antifolate drug treatment, as the
drug may promote their transformation. A better understanding of
the effects of antifolate drugs, on the mechanisms that initiate,
direct, and enable chromosomal instability is of major clinical
importance and might lead to the development of better therapeutic
approaches. An additional well-established phenomenon hindering
the therapeutic potential of antifolate drugs is antifolate resistance
that is frequently developed by several molecular mechanisms such
as qualitative and/or quantitative alterations in influx and/or efflux
transporters of antifolates and in folate-dependent enzymes (Assaraf,
2007; Gonen & Assaraf, 2012). Indeed, this has been our rationale to
establish a modal system that mimics folate deficiency based on
folate-deficient medium rather than antifolate drugs, and mimics
more accurately the gene–nutrition interactions early in cancer
development.
Replication stress is considered to be a complex phenomenon
that has severe implications for genome stability, cell survival, and
human disease. We used folate deficiency as a model to demon-
strate the co-carcinogenic interaction between dietary and genetic
factors that is mediated by their effect on the DNA replication
machinery. It is widely accepted that the initiation of cancer is a
result of a combination of multiple genetic alterations, referred to as
hits. Our results suggest that folate deficiency functions as a non-
genetic hit which in conjunction with oncogene expression can
enforce the cancerous process. Hence, replication stress is a quanti-
tative trait that serves as a molecular mechanism linking oncogene
expression, folate deficiency and cancer development.
Materials and Methods
Cell cultures
Primary human diploid foreskin fibroblasts (BJ cells) expressing a
transfected hTERT (Bodnar et al, 1998) were grown in folate-free
DMEM (custom-made, Biological Industries, Beit Haemek, Israel) or
normal DMEM (Biological Industries, Beit Haemek, Israel). These
concentrations were estimated by the manufacturer. The medium
was supplemented with 5% FBS, 100,000 U/l penicillin, and 100 lg/l
streptomycin. For different folate concentrations, folate-free DMEM
and normal DMEM (containing 9,040 nM folate) were mixed in the
desired ratios. Primary keratenocytes expressing transfected E6/E7
were grown in folate-free RPMI (custom-made, Biological Industries,
Beit Haemek, Israel) or normal RPMI (Biological Industries, Beit
Haemek, Israel) supplemented with 5% FBS, 100,000 U/l penicillin,
and 100 lg/l streptomycin. Mouse immortalized fibroblasts 3T3 cells
transfected with cyclin E or Ras (H-RasV12) and mammary epithelial
cells MCF10A transfected with Ras (H-RasV12) were grown for
4 weeks in a DMEM that contained 100 nM folate (1:90.4 ratio
between normal DMEM and folate-free DMEM, respectively) (Biolog-
ical Industries, Beit Haemek, Israel) supplemented with 5% FBS,
100,000 U/l penicillin, and 100 lg/l streptomycin. Then, they were
maintained two additional weeks in a normal DMEM (Biological
Industries, Beit Haemek, Israel) supplemented with 5% FBS,
100,000 U/l penicillin, and 100 lg/l streptomycin. Control cells were
grown in a normal medium for the whole period.
Retroviral infection
Amphotropic retroviruses expressing cyclin E or Ras (H-RasV12)
were generated by Phoenix retroviral packaging cells according to
established procedures. The cyclin E pBABE-puro-based vector was
kindly provided by Professor J. Bartek. The phoenix cells were
grown in DMEM supplemented with 10% fetal bovine serum (FBS),
and the supernatant was collected. hTERT-expressing BJ cells 3T3
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and MCF10A cells were infected according to established proce-
dures. Primary keratenocytes were infected as was described previ-
ously (Bester et al, 2011).
Molecular combing
Unsynchronized cells were pulse-labeled for 30 min by a medium
containing 100 lM of the thymidine analog iododeoxyuridine
(IdU). At the end of the first labeling period, the cells were washed
twice with a warm medium and pulse-labeled once more for
30 min with a medium containing 100 lM of another thymidine
analog chlorodeoxyuridine (CldU). Cells were then harvested, and
genomic DNA was extracted, combed, and analyzed as previously
described (Lebofsky et al, 2006; Herrick & Bensimon, 2009). The
primary antibody for fluorescence detection of IdU was mouse anti-
BrdU (Becton Dickinson), and the secondary antibody was goat
anti-mouse Alexa Fluor 488 (Invitrogen). The primary antibody for
fluorescence detection of CldU was rat anti-CldU (Novus Biologi-
cals). The secondary antibody was goat anti-rat Alexa Fluor 594
(Invitrogen). The length of the replication signals and the distances
between origins were measured in micrometers and converted to
kilo bases according to a constant and sequence-independent
stretching factor (1 lm = 2 Kb), as previously reported (Herrick &
Bensimon, 2009).
Nucleoside supplementation
The ribonucleosides adenosine, cytidine, guanosine (Sigma), and
deoxyribonucleoside thymidine (Sigma) were freshly prepared for
each experiment, filter-sterilized, and used at 50 lM each in the last
48 h of the experiment.
Soft agar assay
Following cyclin E and Ras (H-RasV12) expression in 3T3 and Ras
(H-RasV12) expression in MCF10A, cells were grown in a DMEM
that contained 100 nM folate for 4 weeks and then two additional
weeks in a normal medium. Control cells were grown in a normal
medium for the whole period. 4 × 103 cells in a growth medium
containing 0.3% agar (50 ll final volume) were plated on the top of
a solid growth medium containing 1% agar (100 ll final volume).
After the medium solidified, an additional 50 ll of growth medium
was added (Agarose, Type VII, Sigma). Colonies were counted after
4–6 weeks of growth.
Animal care
All animal experiments were performed in accordance with the
guidelines of the Hebrew University Committee for the use of
animals for research. Veterinary care was provided to all animals by
the Hebrew University animal care facility staff in accordance with
AAALAC standard procedures and as approved by the Hebrew
University Ethics Committee.
Tumorigenesis assays in nude mice
MCF10A cells expressing H-RasV12 were grown in a DMEM that
contained 100 nM folate for 4 weeks and then two additional weeks
in a normal medium. Control cells were grown in a normal medium
for the whole period. Cells were injected (3 × 106 cells per site in
200 ll of PBS) subcutaneously into each rear flank of 8-week-old
female (Atimic-Nu/Nu) nude mice by using a 26-gauge needle.
Tumor growth was monitored every 10 days. Blinding and random-
ization have not been used.
Immunofluorescence for detection of cH2AX, 53BP1, and
RAD51 foci
BJ cells were fixed in 3.7% formaldehyde/PBS for 10 min, perme-
abilized with 0.5% Triton/PBS, and blocked with 5% BSA/PBS. The
primary antibodies used were mouse anti-cH2AX 1:200 (Upstate
Biotechnology), rabbit polyclonal anti-53BP1 1:200 (Bethyl Labora-
tories), and rabbit polyclonal anti-RAD51 1:200 (EMD MILLIPORE).
Appropriate secondary antibodies were added (Jackson Immuno-
Research Laboratories). Images were taken with a Bio-Rad confocal
microscope. For focus information analysis, at least 65 nuclei for
each condition were analyzed.
Western blotting
8–10% polyacrylamide gels were used for protein separation and
detection. The gels were transferred to a nitrocellulose membrane,
and antibody hybridization and electrochemiluminescence (ECL)
were performed according to standard procedures. The primary
antibodies used in this analysis were rabbit monoclonal anti-
phosphorylated ATM 1:1,000 (Abcam), mouse monoclonal anti-ATM
1:10,000 (sigma), rabbit monoclonal anti-phosphorylated CHK1
1:200 (Cell Signaling), mouse monoclonal anti-CHK1 1:500 (Abcam),
mouse monoclonal anti-cyclin E 1:200 (Santa Cruz Biotech-
nology), and rabbit polyclonal anti-beta actin 1:5,000 (Abcam).
HRP-conjugated anti-rabbit and anti-mouse secondary antibodies
were obtained from Jackson ImmunoResearch laboratories (West
Grove, PA).
Nucleotide pool analysis
Cells were harvested, and cellular nucleotides were extracted with
0.4 N perchloric acid and neutralized with potassium chloride.
Deoxynucleotides were separated from ribonucleotides using a boro-
nate affinity column. Deoxynucleotides were analyzed by HPLC
using UV absorbance at 254 and 281 nm for identification and quan-
titation as previously described (Flanagan et al, 2007).
Statistics
A summary of the number of repeats for each experiment and the
exact P-value and the statistical tests that have been employed
can be found in Appendix Table S1. In summary, replication dynam-
ics experiments, immunofluorescence experiments, and soft agar
experiments were performed at least three independent times. Two-
tailed Student’s t-tests were performed to determine significant
differences between treatment groups. Fisher’s exact test was
performed to determine significant differences in the symmetry of
fork progression. To determine overall tumor development in mice,
we used a log-rank (Mantel–Cox) test. Quantitative analyses were
conducted blindly.
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Expanded View for this article is available online:
http://embomolmed.embopress.org
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The paper explained
Problem
Chromosomal instability is a hallmark of cancer. An enormous effort has
been made to understand the effects of genetic, environmental, and
dietary factors on genomic instability. In recent years, it has become
evident that replication stress-induced DNA damage caused by aberrant
oncogene expression plays a prominent role in driving genomic instabil-
ity in early cancer stages. However, whether the extent of replication
stress can affect the probability of neoplastic transformation remains
elusive. Moreover, whether enhanced replication stress can be driven by
a combination of genetic, dietary, and environmental factors is largely
unknown. Here, we investigated the role of folate deficiency, a micronu-
trient that is essential for DNA replication, in modulating oncogene-
induced DNA damage and tumorigenicity.
Results
We show that replication-induced genome instability can be affected
by both genetic and non-genetic factors such as folate. We show that
folate deficiency by itself leads to replication stress in a concentration-
dependent manner. Furthermore, folate deficiency significantly
enhances oncogene-induced replication stress, leading to increased
DNA damage and tumorigenicity in vitro. Importantly, oncogene-
expressing cells grown under folate deficiency show a significantly
increased frequency of tumor development in mice. These findings indi-
cate that replication stress is a quantitative trait that can be affected by
both genetic and non-genetic (e.g., dietary) factors and that the extent
of the replication stress plays an important role in cancer development.
Impact
Replication stress is considered to be a complex phenomenon that
has serious implications for genome stability, cell survival, and human
disease. We used folate deficiency, one of the most common micronu-
trient deficiencies, as a model to demonstrate the co-carcinogenic
interaction between dietary and genetic factors is mediated by their
effect on the DNA replication machinery. It is widely accepted that
the initiation of cancer is a result of a combination of multiple
genetic alterations, referred to as hits. Our results suggest that
micronutrient deficiencies might also function as a “hit” which in
conjunction with oncogene expression can enforce the cancerous
process. Moreover, we showed that even a mild transient folate defi-
ciency is sufficient to disrupt genome integrity and enhance tumori-
genicity, since DNA damage that had been generated under
conditions of folate deficiency is irreversible and thus cannot be
recovered after later folate supplementation. This may pave the way
toward the development of new approaches and recommendations to
prevent cancer development.
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